WMP
GILD icon

Wealth Management Partners’s Gilead Sciences GILD Stock Holding History

Wealth Management Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,605
Closed -$247K – 115
2024
Q2 		$247K Buy
+3,605
New +$241K 0.12% 92
2024
Q1 		– Sell
-2,603
Closed -$211K – 121
2023
Q4 		$211K Sell
2,603
-124
-5% -$9.65K 0.12% 112
2023
Q3 		$204K Buy
+2,727
New +$210K 0.13% 114

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wealth Management Partners's GILD Position: Q3 2024 in Review

Wealth Management Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 3,605 shares — an estimated $247K sold.

Wealth Management Partners first reported a position in GILD in Q3 2023 and held it in 3 quarters. The position peaked at $247K in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Wealth Management Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Wealth Management Partners sold 3,605 Gilead Sciences shares in Q3 2024, an estimated $247K.
  • Wealth Management Partners first reported a position in Gilead Sciences in Q3 2023 and held it in 3 quarters.
  • Wealth Management Partners's Gilead Sciences position peaked at $247K in Q2 2024.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Wealth Management Partners's 13F filing for Q3 2024, filed 21 Oct 2024.